Skip to main content Accessibility help
×
Home

Cost-effectiveness evaluation of compliance therapy for people with psychosis

  • Andrew Healey (a1), Martin Knapp (a1), Jack Astin (a1), Jennifer Beecham (a1), Roisin Kemp (a2), Anthony David (a3) and George Kirov (a4)...

Abstract

Background

Non-compliance rates with antipsychotic medication can be high, and the personal and societal costs are considerable. A new psychological intervention, compliance therapy seeks to improve compliance and patient outcomes and reduce treatment costs.

Method

A randomised controlled study examined the cost-effectiveness of compliance therapy compared to nonspecific counselling over 18 months for 74 people with psychosis admitted as inpatients at the Maudsley Hospital. Bivariate and multivariate analyses were conducted to test for differences and to explore inter-patient cost variations.

Results

Compliance therapy is more effective and is no more expensive. Consequently, compliance therapy is more cost-effective than non-specific counselling at six, 12 and 18 months.

Conclusions

There are compliance, outcome and cost-effectiveness arguments in favour of compliance therapy in preference to non-specific counselling.

Copyright

Corresponding author

Mr Andrew Healey, Centre for the Economics of Mental Health, Institute of Psychiatry, De Crespigny Park, London NW3 2QG

Footnotes

Hide All

Related paper pp. 413–419, this issue.

Footnotes

References

Hide All
American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders (3rd edn, revised) (DSM–III–R). Washington, DC: APA.
Barnes, T. R. E. (1989) A rating scale for drug induced akathisia. British Journal of Psychiatry, 54, 672676.
Beecham, J. K. & Knapp, M. R. J. (1991) Costing psychiatric interventions. In Measuring Mental Health Needs (eds G. Thornicroft, C. Brewin & J. K. Wing), pp. 163183. London: Gaskell.
Corrigan, P. W., Liberman, R. P. & Engel, J. D. (1990) From non-compliance to collaboration in the treatment of schizophrenia. Hospital and Community Psychiatry, 41, 12031211.
David, A. S. (1990) Insight and psychosis. British Journal of Psychiatry. 156, 798808.
Hale, T. (1993) Will the new antipsychotics improve the treatment of schizophrenia. British Medical Journal, 307, 749750.
Hayward, P., Chan, N., Kemp, R., et al (1995) Medication self-management: a preliminary report on an intervention to improve medication compliance. Journal of Mental Health, 4, 511517.
Hogan, T. P., Awad, A. G. & Eastwood, R. (1983) A self report scale predictive of drug compliance in schizophrenia: reliability and discriminative validity. Psychological Medicine, 13, 177183.
Lukoff, D., Nuechterlein, K. H. & Ventura, J. (1996) Manual for the expanded BPRS. Schizophrenia Bulletin, 12, 594602.
Kemp, R., David, A. & Hayward, P. (1996a) Compliance therapy: an intervention targeting insight and treatment adherence in psychotic patients. Behavioural and Cognitive Psychotherapy, 24, 331350.
Kemp, R., Hayward, P., Applethwaite, G., et al (1996b) Compliance therapy in psychotic patients: a randomised controlled trial. British Medical Journal, 312, 345349.
Kemp, R., & Hayward, P., (1997) Insight and compliance. In Compliance and the Treatment Alliance in Serious Mental Illness. Newark: B. Blackwell, Gordon and Breach Publishing Group.
Kemp, R., Kirov, G., Everitt, B., et al (1998) A randomised controlled trial of compliance therapy: 18 month follow-up. British Journal of Psychiatry, 172, 413419.
MacPhillips, M. & Sensky, T. (1998) Coercion, adherence or collaboration? Influences on compliance with medication. In Innovation in the Psychological Treatment of Schizophrenia (ed. Wykes, T.). Chichester: John Wiley, in press.
Nelson, H. E. (1982) National Adult Reading Test (NART): Test Manual. Windsor: NFER.
Netten, A. & Dennett, J. (1996) Unit Costs of Health and Social Care 1996. Personal Social Services Research Unit, University of Kent at Canterbury.
Simpson, G. M. & Angus, J. W. S. (1970) Drug-induced extrapyramidal disorders. Acta Psychiotrica Scandinavica, 45 (suppl. 212): 1119.
Weiden, P. J. & Olfson, M. (1995) Costs of relapse in schizophrenia. Schizophrenia Bulletin, 21, 419429.

Related content

Powered by UNSILO

Cost-effectiveness evaluation of compliance therapy for people with psychosis

  • Andrew Healey (a1), Martin Knapp (a1), Jack Astin (a1), Jennifer Beecham (a1), Roisin Kemp (a2), Anthony David (a3) and George Kirov (a4)...

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.

Cost-effectiveness evaluation of compliance therapy for people with psychosis

  • Andrew Healey (a1), Martin Knapp (a1), Jack Astin (a1), Jennifer Beecham (a1), Roisin Kemp (a2), Anthony David (a3) and George Kirov (a4)...
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *